Adalimumab-adbm injection, a biosimilar to Humira ® (adalimumab), has been made available by Boehringer Ingelheim. Adalimumab-adbm injection is an interchangeable biosimilar and can be substituted for ...

Medicare Part D may cover Humira when a person can self-administer it at home. A person’s Part D costs for Humira will depend on the plan’s formulary and their specific plan. Similarly, Medicare ...

Boehringer Ingelheim’s Adalimumab-adbm injection, the company’s interchangeable biosimilar to Humira (adalimumab), is now available at a low wholesale acquisition cost. Adalimumab-adbm is approved to ...

GoodRx (GDRX) announced a new partnership with Boehringer Ingelheim to provide discounts for a biosimilar to rheumatoid arthritis drug Humira Thursday, adding to an increasingly competitive market.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Cigna Group-owned Evernorth Health Services said Thursday it would provide a Humira biosimilar with no out-of-pocket fees starting in June. The pharmacy and benefits provider said the biosimilar for ...

Abbott Laboratories announced today that the U.S. Food and Drug Administration has granted expanded indication to the Company's HUMIRA treatment to include inhibiting progression of structural joint ...

WASHINGTON (Reuters) - Abbott Laboratories Inc won a U.S. panel's support on Tuesday for wider use of its blockbuster rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel ...